The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the prevention of death, myocardial infarction or stroke. The findings, from...
NICE has today (21 October) published final draft guidance recommending the wider use of clopidogrel for the prevention of occlusive vascular events (ischaemic stroke , transient ischaemic attack [TIA] or heart attack) in people who have previously had an ischaemic stroke, or who have been...